covalsar-denk 160/12.5
denk pharma gmbh & co. kg - valsartan, hydrochlorothiazide - tablets film-coated - 160mg+12,5mg
covalsar-denk 320/12.5
denk pharma gmbh & co. kg - valsartan, hydrochlorothiazide - tablets film-coated - 320mg+12,5mg
glimepiride denk 3 tablets
denk pharma gmbh & co. kg - glimepiride - tablets - 3mg
glimepiride denk 2 tablets
denk pharma gmbh & co. kg - glimepiride - tablets - 2mg
glimepiride denk 2 tablets
denk pharma gmbh & co. kg - glimepiride - tablets - 2mg
glimepiride denk 3 tablets
denk pharma gmbh & co. kg - glimepiride - tablets - 3mg
fosinopril + hydrochlorothiazide aurobindo 20mg + 12.5mg, tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - fosinopril sodium, hydrochlorothiazide - tablet - fosinopril sodium 20 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
imprida hct
novartis europharm ltd. - amlodipine, valsartan, hydrochlorothiazide - hypertension - angiotensin ii antagonists, plain, angiotensin ii antagonists, combinations - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.
rasitrio
novartis europharm ltd. - aliskiren, amlodipine, hydrochlorothiazide - hypertension - cardiovascular system - rasitrio is indicated for the treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of aliskiren, amlodipine and hydrochlorothiazide given concurrently at the same dose level as in the combination.